Type Title Author Comments Last updated
Post Regulating gut bacteria could reduce side-effects of chemotherapy Owen 0 9 hours 35 minutes ago
Post Wide variation in colorectal cancer rates after colonoscopies in England Owen 0 10 hours 40 minutes ago
Post Certain gut bacteria maybe involved in causing bowel cancer Owen 0 1 week 1 day ago
Post ACP issues guidance for colorectal cancer screening Owen 0 1 week 1 day ago
Post Medtronic launches the first artificial intelligence system for colonoscopy Owen 0 1 week 1 day ago
Post Ulcerative Colitis: vedolizumab out performs adalimumab for clinical remission and endoscopic improvement Owen 0 2 weeks 1 day ago
Post Study provides new insights into colon function Owen 0 2 weeks 1 day ago
Post Positive outcomes for patients 85 years and older after colectomies Owen 0 2 weeks 1 day ago
Post Genetic testing bowel cancer patients could save lives and money Owen 0 2 weeks 1 day ago
Post Irritable Bowel Syndrome researchers identify cause gut itch Owen 0 2 weeks 3 days ago
Post Researchers find mTORC2 protein is not active in colorectal cancer Owen 0 2 weeks 3 days ago
Post New insights uncovering the pathway to colon cancer Owen 0 2 weeks 3 days ago
Post Cancer risk increases for individuals who are overweight before 40 Owen 0 2 weeks 3 days ago
Post Research shows lower rates of cancer screening in women with diabetes Owen 0 2 weeks 3 days ago
Post Colorectal and pancreatic cancer rates up 10% in last 30 years Owen 0 2 weeks 3 days ago
Post IBD prevalence three times higher than estimates and expected to rise Owen 0 2 weeks 3 days ago
Post Colorectal surgery patients use fewer opioids and less pain after ERAS Owen 0 2 weeks 3 days ago
Post Mutant protein could determine development of colon cancer Owen 0 4 weeks 1 day ago
Post Researchers develop treatment for familial adenomatous polyposis Owen 0 4 weeks 1 day ago
Post Routine bowel cancer testing for all over 50s not beneficial Owen 0 4 weeks 1 day ago
Post Genetic variant has potential to personalise Crohn's disease treatment Owen 0 4 weeks 1 day ago
Post High-intensity surveillance colonoscopy reduces CRC risk Owen 0 1 month 2 weeks ago
Post Differences in mortality from colorectal cancer across US cities Owen 0 1 month 2 weeks ago
Post Why some colorectal cancer patients with a certain gene mutation benefit from a chemotherapy with cetuximab Owen 0 1 month 2 weeks ago
Post Ethicon launches first powered circular stapler for colorectal surgery Owen 0 1 month 2 weeks ago

Latest posts

Ulcerative Colitis: vedolizumab out performs adalimumab for clinical remission and endoscopic improvement

The IKBFU center for clinical research scientists have participated in the international VARSITY clinical research study, the world's first study aimed at finding the most effective drug among anti-inflammatory drugs for the treatment of ulcerative colitis. The results, ‘Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis’, were published in The New England Journal of Medicine.

6th Portsmouth CME Symposium

Start Date
26 May 2020
End Date
28 May 2020
Organisers/Society/Association
Queen Alexandria Hospital and the University of Portsmouth
Location
Lakeside 2000 Auditorium

Study finds Cook Medical’s Hemospray is 98% successful in treating GI bleeding

A new, multi-centre study on Cook Medical’s Hemospray Endoscopic Hemostat device has revealed that the use of Hemospray demonstrated a more than 98% successful hemostasis rate, while the 30-day rebleeding rate was 10%. The results, ‘Successful hemostasis of active lower GI bleeding using a hemostatic powder as monotherapy, combination therapy, or rescue therapy’, were published in the April 2019 edition of Gastrointestinal Endoscopy.

New approach to bowel cancer analysis could lead to better prognosis for patients

Researchers from Queen’s University have demonstrated how a precise integration of the results of both pathological and molecular analysis of tumour and normal tissue from the bowel can ensure a correct interpretation of the data, providing a more accurate result that can underpin better treatment options for bowel cancer patients. The paper, ‘Epithelial-to-mesenchymal transition signature assessment in colorectal cancer quantifies tumour stromal content rather than true transition,’ in the journal The Journal of Pathology.

Ten-year follow-up after negative colonoscopies linked to lower colorectal cancer risk

Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal cancer screening, according to a study, ‘Long-term Risk of Colorectal Cancer and Related Deaths After a Colonoscopy With Normal Findings’, published in JAMA Internal Medicine.